Diabetes drugmaker Novo Nordisk presented a post-hoc analysis of the SUSTAIN 7 trial comparing treatment effect in body weight across baseline BMI subgroups receiving Novo's Ozempic or Eli Lilly's ...

Novo Nordisk makes Ozempic, one of the leading drugs in the market. United Labs also released its annual earnings results today. Net profit fell 1.5 percent to CNY2.66 billion (USD367 million) in the ...